• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

A Study of Srum Homocysteine Level in Ischaemic Stoke
CONCLUSION: The present study revealed that hyperhomocysteinemia appears to be an important risk factor for ischemic stroke. It is therefore important to use serum homocysteine as an important tool to investigate all cases of ischemic stroke and if serum homocysteine is elevated patient should be put on multivitamins containing vitamin B12, folic acid and pyridoxine to reduce serum homocysteine levels.PMID:35443421
Source: Atherosclerosis - April 21, 2022 Category: Cardiology Authors: Kaushik Paul Ramakrishna Mr Source Type: research

Rescue Strategies in Anterior Circulation Stroke with Failed Mechanical Thrombectomy-A Retrospective Observational Study (RAFT)
CONCLUSIONS: Rescue stenting and/or angioplasty after failed MT is a safe and effective recanalization method for AIS in anterior circulation without increasing mortality or morbidity.PMID:35359559 | PMC:PMC8965932 | DOI:10.4103/aian.AIAN_87_21
Source: Atherosclerosis - April 1, 2022 Category: Cardiology Authors: Amit Ashok Bhatti Niranjan P Mahajan Devashish Dhiren Vyas Mudasir Mushtaq Shah Vikram Huded Source Type: research

Risk factors predisposing to acute stroke in India: a prospective study
Conclusion: The foremost risk factors for stroke in India, hypertension and diabetes, need to be controlled and treated like other global high-risk populations for stroke prevention. The NIHSS scores highlight the relationship between risk factors and stroke severity.
Source: Journal of Hypertension - October 15, 2021 Category: Cardiology Tags: ORIGINAL PAPERS: Risk factors Source Type: research

Incidence and impact of ischemic and hemorrhagic stroke after left ventricular assist device implantation: A nationwide study
ConclusionThe incidence of stroke was ~7% after LVAD placement, and it was associated with significantly higher in-hospital mortality and resource utilization.
Source: Indian Heart Journal - October 6, 2019 Category: Cardiology Source Type: research

Thrombolysis with Reteplase in Acute Pulmonary Embolism
ConclusionsDouble bolus reteplase given with heparin is effective in the treatment of high, intermediate risk pulmonary embolism with minimal risk of bleeding.
Source: Indian Heart Journal - September 22, 2019 Category: Cardiology Source Type: research

Incidence and Impact of Ischemic and Hemorrhagic Stroke post Left Ventricular Assist Device Implantation: A Nationwide Study
ConclusionThe incidence of stroke was ∼7% after LVAD placement and it was associated with significantly higher in-hospital mortality and resource utilization.
Source: Indian Heart Journal - September 14, 2019 Category: Cardiology Source Type: research

Incidence and impact of ischemic and hemorrhagic stroke after left ventricular assist device implantation: A nationwide study.
CONCLUSION: The incidence of stroke was ~7% after LVAD placement, and it was associated with significantly higher in-hospital mortality and resource utilization. PMID: 32035527 [PubMed - in process]
Source: Indian Heart J - August 31, 2019 Category: Cardiology Authors: Thakkar S, Rupareliya C, Doshi R Tags: Indian Heart J Source Type: research

Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials
ConclusionsIntravenous TNK-tPA 0.2  mg/kg administered within 3 hours of symptom onset seems to be well tolerated and effective option in patients with acute ischemic stroke.Trial RegistrationClinical Trials Registry —India,www.ctri.nic.in; unique identifiers: CTRI/2009/091/000251 and CTRI/2015/02/005556.
Source: American Journal of Cardiovascular Drugs - October 1, 2018 Category: Cardiology Source Type: research

Pharmacologic Reperfusion Therapy with Indigenous Tenecteplase in 15,222 patients with ST Elevation Myocardial Infarction - The Indian Registry.
CONCLUSION: This study confirms the safety and efficacy of indigenous tenecteplase in Indian patients with STEMI, including high risk subgroups. It also highlights the fact that delayed treatment denotes denial of benefits of pharmacologic reperfusion therapy. PMID: 23993004 [PubMed - in process]
Source: Indian Heart J - July 1, 2013 Category: Cardiology Authors: Iyengar SS, Nair T, Hiremath JS, Jadhav U, Katyal VK, Kumbla D, Sathyamurthy I, Jain RK, Srinivasan M Tags: Indian Heart J Source Type: research